A Better Path for Cancer Diagnostics - Dako
A Better Path for Cancer Diagnostics - Dako
A Better Path for Cancer Diagnostics - Dako
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
INVITATION<br />
ECP<br />
24th European Congress of <strong>Path</strong>ology<br />
September 8 – 12, 2012 I Prague Congress Centre, Czech Republic<br />
A <strong>Better</strong> <strong>Path</strong> <strong>for</strong><br />
<strong>Cancer</strong> <strong>Diagnostics</strong>
INVITATION<br />
ECP<br />
24th European Congress of <strong>Path</strong>ology<br />
September 8 – 12, 2012 I Prague Congress Centre, Booth 36<br />
Visiting ECP? Let’s start by saving you time.<br />
At the 24th ECP we’ll be demonstrating the HER2 IQFISH pharmDx that delivers in situ<br />
hybridization results in just 3½ hours—instantly improving patient care.<br />
We will also present our new antibodies to MSH2, MSH6 and PMS2, which, together with<br />
MLH1, complete the mismatch repair antibody panel.<br />
And don’t miss the new Artisan Link Pro <strong>for</strong> special staining. It is the next generation<br />
of <strong>Dako</strong>’s renowned Artisan Staining Systems, and the first instrument to provide true<br />
walk-away automation <strong>for</strong> complex special stains.<br />
Register today to join us at our Scientific Symposium focused this year on per<strong>for</strong>mance<br />
evaluation and clinical perspectives on IQFISH.<br />
Visit us at Booth 36 to learn about the latest scientific advancements from <strong>Dako</strong><br />
that bring certainty to cancer diagnostics.
ISH: From more than 17 hours to 3½ hours. It’s about time.<br />
When it comes to cancer diagnostics, time is everything. Now a new technology from<br />
<strong>Dako</strong> will change the rules of time. Visit www.dako.com/iqfish.<br />
<strong>Dako</strong> introduces Instant Quality FISH<br />
The graph illustrates how the IQFISH, with just one hour hybridization, reduces assay time from 17 hours to just three<br />
hours and thirty minutes. This opens up new possibilities <strong>for</strong> laboratory efficiency with the same high quality results.
INVITATION<br />
ECP<br />
<strong>Dako</strong> Scientific Symposium<br />
September 10 I 12:45 – 14:15 I Prague Congress Centre I North Hall<br />
Welcome and introduction<br />
By Prof. Giuseppe Viale, MD, FRC<strong>Path</strong>, European Institute of Oncology and University of Milan, Italy<br />
Per<strong>for</strong>mance evaluation – Results from clinical pathology laboratories in Europe<br />
Intra-laboratory comparison study<br />
By Prof. Josef Rüschoff, Chief Medical Officer of targos molecular pathology gmbh, Kassel, Germany<br />
Inter-laboratory comparison study involving five French breast cancer institutions<br />
By Dr. Magali Lacroix-Triki, MD, Institut Claudius Regaud, Toulouse, France<br />
Inter-laboratory comparison study involving three Spanish breast cancer institutions<br />
By Dr. David Hardisson, University Hospital La Paz, School of Medicine, Autonomous University of Madrid,<br />
IdiPAZ, Madrid, Spain<br />
Clinical perspectives<br />
How will this new technology change the use of ISH and breast cancer diagnostics<br />
and the values <strong>for</strong> the oncologist and patients<br />
By Prof. Giuseppe Viale, MD, FRC<strong>Path</strong>, European Institute of Oncology and University of Milan, Italy
Register today.<br />
Attend our satellite symposium to listen to what these distinguished<br />
experts and thought leaders in the field of pathology have to say about<br />
the advancement of cancer diagnostics today.<br />
For more background on the speakers<br />
and to view the full program, go to:<br />
www.dako.com/ecp<br />
Seats are limited, so please register<br />
your attendance online today at:<br />
www.dako.com/ecp
INVITATION<br />
ECP<br />
24th European Congress of <strong>Path</strong>ology<br />
September 8 – 12, 2012 I Prague Congress Centre, Booth 36<br />
Relentless in our commitment<br />
to fighting cancer. Together.<br />
Corporate Headquarters<br />
Denmark<br />
+45 44 85 95 00<br />
www.dako.com<br />
Represented in more<br />
than 80 countries<br />
Australia<br />
+61 3 9357 0892<br />
Austria<br />
+43 1 408 43 34 0<br />
Belgium<br />
+32 (0) 16 38 72 20<br />
Brazil<br />
+55 11 50708300<br />
Canada<br />
+1 905 335 3256<br />
China<br />
+86 21 6327 1122<br />
Denmark<br />
+45 44 85 97 56<br />
Finland<br />
+358 9 348 73 950<br />
France<br />
+33 1 30 50 00 50<br />
Germany<br />
+49 40 69 69 470<br />
Ireland<br />
+353 1 479 0568<br />
Italy<br />
+39 02 58 078 1<br />
Japan<br />
+81 3 5802 7211<br />
The Netherlands<br />
+31 20 42 11 100<br />
Norway<br />
+47 23 14 05 40<br />
Poland<br />
+48 58 661 1879<br />
Spain<br />
+34 93 499 05 06<br />
Sweden<br />
+46 8 556 20 600<br />
Switzerland<br />
+41 41 760 11 66<br />
United Kingdom<br />
+44 (0)1 353 66 99 11<br />
United States of America<br />
+1 805 566 6655<br />
50117 26JUL12
Change language